Introduction BACKGROUND  N on-sustained VT (NSVT) is a known risk factor for poor outcomes in adults with HCM and diastolic dysfunction is linked to poor.

Slides:



Advertisements
Similar presentations
CMR of Non-ischemic Dilated and Restrictive Cardiomyopathies
Advertisements

Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure Fonarow GC et al. J Am Coll Cardiol 2007; 49(19):
TWA Testing in the EP Lab u To guide performance of EP study u To guide interpretation of EP study u To provide independent information along with the.
Azin Alizadehasl, MD. Sarcoidosis is a systemic inflammatory disease of unknown etiology, characterized by non-caseating granulomas. It mainly affects.
Manoel Otávio da Costa Rocha UNIVERSIDADE FEDERAL DE MINAS GERAIS - FACULDADE DE MEDICINA PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS DA SAÚDE: INFECTOLOGIA.
Hypertrophic Cardiomyopathy Guidelines Summary from the: ACC/ESC Clinical Expert Consensus Statement on Hypertrophic Cardiomyopathy Maron BJ, et al. J.
Implantable Cardioverter Defibrillators to Prevent Sudden Cardiac Death: Background Frederick A. Masoudi, MD, MSPH Associate Professor of Medicine (Cardiology)
Comparison of Echocardiographic Methods to Cardiac Magnetic Resonance Imaging in Survivors of Pediatric Cancer Jeet Mehta 1, Sanket Shah 1,2 Wendy McClellan.
Left Ventricular Hypertrophy Detection, significance and treatment.
Overview of Adult Cardiovascular Disease Social Security Administration Compassionate Allowances Outreach Hearing on Cardiovascular Disease and Multiple.
Cardiac Issues in Friedreich’s Ataxia 2 nd Annual Friedreich’s Ataxia Symposium Robert E. Shaddy, MD Jennifer Terker Professor of Pediatrics Division Chief,
Prognostic Implications of Left Ventricular Mass and Geometry Following Myocardial Infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) Echocardiographic.
Investigator Investigator: Sharma Kattel, MBBS Mentor: Mentor: Yuji Saito, MD, PhD, FACP, FACC Department of Internal Medicine Sisters of Charity Hospital.
Ventricular Diastolic Filling and Function
The Relationship Between Renal Function and Cardiac Structure, Function, and Prognosis Following Myocardial Infarction: The VALIANT Echo Study Anil Verma,
Lead author No. patients Patient groupPrimary outcomesPositive ResultsStatistical significance Rohde 1 570Elective major non-cardiac surgery Primary cardiac.
Does asymptomatic patients with very frequent ventricular ectopy need prophylactic catheter ablation to prevent the development of cardiomyopathy Minglong.
Restrictive Physiology is a Major Predictor of Poor Outcomes in Children with Hypertrophic Cardiomyopathy Shiraz A Maskatia MD, Jamie A Decker MD, Joseph.
Left Ventricular Dyssynchrony Acutely After Myocardial Infarction Predicts Left Ventricular Remodeling Sjoerd A. Mollema 1, Su San Liem 1, Matthew S. Suffoletto.
The transmural extent of late gadolinium enhancement detected with cardiovascular magnetic resonance in collateral dependent myocardium. Does a good collateral.
Introduction/Abstract Background: In-hospital trauma team activation criteria are formulated to identify severely injured patients needing specialized,
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Life Threatening Ventricular Arrhythmias: Current Role of.
Thomas Wilson 1,2,3, Vijay Krishnamoorthy MD 1,2, Edward Gibbons MD 4, Ali Rowhani-Rahbar MD MPH PhD 2,5, Adeyinka Adedipe MD 6, Monica S. Vavilala MD.
Serviço de Cardiologia Hospital de Santa Maria Centro Hospitalar Lisboa Norte Subclinical focal fibrosis and abnormal strain in patients with sarcoidosis.
© 2008, American Heart Association. All rights reserved. AHA/ACC/HRS Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying.
Intravenous Erythropoietin in Patients with ST-Segment Elevation MI -- Study performed by: Najjar et al -- Presented by: Jay Hall PA-SII, Ali Rahimi MD.
Insert Program or Hospital Logo Introduction ► Due to changes in delivery room practices, improvement in clinical care, and limitations on the time spent.
TAHAR EL KANDOUSSI, SARA ECHERKI, NAWAL DOGHMI, MOHAMED CHERTI. SEcurite de l’Echocardiographie de stress : plutôt l’effort. Cardiology B Department, Ibn.
Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: Spectrum and prognostic significance of arrhythmias.
Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients with Heart Failure with preserved Ejection Fraction Effect of Spironolactone.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pregnancy in Patients With Pre-Existing Cardiomyopathies.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prediction of Cardiac Events in Patients With Reduced.
Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease Angela Y-M Wang, Mei Wang, Christopher W-K Lam,
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Myocardial Perfusion Reserve and Strain-Encoded.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Defining the Natural History of Uremic Cardiomyopathy.
Date of download: 6/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Cardiac Imaging and Stress Testing Asymptomatic.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.
Ventricular Arrhythmias:A General Cardiologist’s Assessment of Therapies in 2004 C.Richard Conti M.D. MACC.
Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: Toward clinical risk assessment inhypertrophic cardiomyopathy.
Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: Frequency and clinical expression of cardiac troponin.
Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Fibrosis With Mortality and Sudden.
Introduction (Background and Purpose/objectives)  Food allergy is a serious medical condition affecting nearly 6 million or 8% of children 1 with prevalence.
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: LV Noncompaction Cardiomyopathy or Just a Lot of.
British Society of Cardiovascular Magnetic Resonance
Disclosures None.
A Case of Elderly Women with Biventricular Hypertrophic Cardiomyopathy
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology The Prognostic value of Heart Rate Response during Vasodilator.
Revascularization in Patients With Left Ventricular Dysfunction:
Three cases illustrating the importance of the endocardial extent of infarction and its location for the QRS score. A. A small transmural, non–Q wave myocardial.
Utility of Cardiac MRI in Diagnosing Fabry’s Cardiomyopathy
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Prediction of 14-year cardiovascular outcomes by dobutamine.
Iacopo Olivotto Unit Cardiomiopatie
Figure 10 Assessment of myocardial fibrosis
Figure 3 T1 mapping and late gadolinium enhancement (LGE)
Figure 6 Risk stratification in hypertrophic cardiomyopathy (HCM)
The Hypertension in the Very Elderly Trial (HYVET)
Francisco Leyva et al. JACC 2017;70:
Sudden cardiac death: The role of imaging
Echocardiography findings in HFNEF
Figure 5 Genotype-positive hypertrophic
The effect of GOODCOLL versus POORCOLL on LVEF, LVEDV and scar at 4 months. The effect of GOODCOLL versus POORCOLL on LVEF, LVEDV and scar at 4 months.
Nat. Rev. Cardiol. doi: /nrcardio
Bar chart of systolic function in healthy individuals, HCM LVH− patients and HCM LVH+ patients. GLS was significantly worse in the HCM LVH+ patients compared.
Bar chart of cardiac volumes and EF in the healthy individuals, HCM LVH− patients and HCM LVH+ patients. Blue bars show the indexed diastolic volumes (EDVI.
A representative patient with dyskinetic apical contraction.
Examples of association between CMR features and abnormal Q waves.
A representative patient with normal apical contraction.
Scatter plot of relationship between MWT, GLS and EF upper panel shows that GLS was closely related to MWT with worse LV function by GLS correlating to.
Illustration of discordance between location of Q waves on ECG derivations and location of LGE in the myocardium on CMR. (A) Incidence of LGE within cited.
Heritability estimates in percentages using structural equations modelling for primary trait phenotypes in DCM (LVEF and LVEDD), HCM (IVSd) and LQTS (QTc).
Presentation transcript:

Introduction BACKGROUND  N on-sustained VT (NSVT) is a known risk factor for poor outcomes in adults with HCM and diastolic dysfunction is linked to poor outcomes in children with HCM  Cardiac Magnetic Resonance (CMR) is the gold standard for assessment of LV mass and can detect late gadolinium enhancement (LGE), which represents myocardial fibrosis  LGE is common in adults with HCM  Incidence of LGE and the clinical utility of CMR and LGE evaluation in children with HCM are unknown OBJECTIVE  Describe CMR characteristics in children with HCM  Determine the association of LGE and LV mass with NSVT and diastolic parameters in children with HCM Utility of Late Gadolinium Enhancement and Left Ventricular Mass as Assessed by Cardiac Magnetic Resonance in Children With Hypertrophic Cardiomyopathy Joseph A Spinner MD, Cory V Noel MD, Susan W Denfield MD, Rajesh Krishnamurthy MD, Aamir Jeewa MD, William J Dreyer MD, Shiraz A Maskatia MD Resident – Baylor College of Medicine  39 patients with CMR and echo images  LGE assessed in 33/39 patients (85%)  LGE was present in 17/33 (52%) with a predilection for the interventricular septum  Presence of LGE associated with greater LV mass, maximum LV thickness, and number of LV segments with hypertrophy  Each additional segment of LGE increased the odds of having NSVT (OR 1.4; 95% CI )  LGE < 5 segments had NPV of 89% for NSVT  LGE in specific LV segments associated with NSVT  Greater maximum LV thickness was associated with NSVT (OR 2.9; 95% CI )  LV Mass correlated with a higher Mitral E/e’ ratio (Rp 0.71, p<0.01) Results Abstract Cardiac magnetic resonance (CMR) has emerged as a tool to risk- stratify adult patients with hypertrophic cardiomyopathy (HCM). The incidence of late gadolinium enhancement (LGE) and the prognostic value of CMR in children with HCM are unknown. The purpose of this study was to determine the association between the extent of LGE and LV mass index (LVMI) as evaluated by CMR with known risk factors for poor outcomes in children with HCM. We retrospectively reviewed CMR and echocardiography studies, and a blinded observer reviewed studies for the number of LV segments with LGE. We compared the CMR findings to known risk factors for poor outcomes. CMR imaging was performed in 39 patients with HCM; evaluation of LGE was performed in 33 (85%) patients of which 17 (52 %) displayed LGE. NSVT was present in 7 patients of which 5 (71%) had LGE (OR 2.92; 95% CI 0.48 –17.9). LGE in specific segments was associated with NSVT. Furthermore, each additional segment of LGE increased the odds of NSVT (OR 1.4; 95% CI ) and having fewer than 5 segments with LGE had a strong negative predictive value of 89% for the presence of NSVT (OR 0.06; 95% CI ). The average LVMI in patients with NSVT was 76.4 ± 40.4 g/m 2.7 compared with 50.9 ± 24.3 g/m 2.7 in those without NSVT (p=0.03). One patient in our cohort underwent heart transplant, one patient experienced aborted sudden death, and no patients died. In conclusion, LGE was common in children with HCM who underwent CMR at our institution. The extent of LGE, assessed by the number of involved LV segments, was associated with NSVT, a known risk factor for sudden cardiac death in HCM. Increased LVMI calculated by CMR was also associated with NSVT. Furthermore, increased LVMI was associated with an elevated mitral annular E/e’ ratio assessed by echocardiography, which is a marker of diastolic dysfunction and known predictor of poor outcomes in children with HCM. While clinical events were rare in our cohort, our data demonstrates the clinical utility of CMR in pediatric patients with HCM and suggests new ways to risk stratify pediatric patients with HCM. Description of intervention/study Conclusions  LGE was common in children with HCM who underwent CMR at our institution  LGE was present in many LV segments without hypertrophy  Pattern of LGE was associated with NSVT  LGE in specific segments was associated with NSVT  Extent of LGE increased odds of having NSVT  Each additional LV segment with LGE increased the odds of NSVT  Fewer than 5 segments with LGE had strong NPV  Increasing LVMI was associated with NSVT  Increasing LVMI was associated with markers of diastolic dysfunction  These data suggest important roles of LGE assessment and the determination of LV mass in the care of children with HCM  Prospective study is necessary to assess the incidence of LGE in children with HCM and associated outcomes References 1.Maron JAMA Cannon RO III, N Engl J Med McMahon et al. Circulation Maskatia et al. Pediatr Cardiol Olivotto, et al. J Am Coll Cardiol, Green et al. JACC Cardiovascular Imaging, Moon et al. J Am Coll Cardiol, Adabag, et al. J Am Coll Cardiol 2008 Texas Pediatric Society Electronic Poster Contest Retrospective review of CMR and echo studies of patients with HCM performed at our center from 2005 – 2013 as part of routine clinical care. All echos reviewed were performed within one year of CMR A blinded expert reviewed all CMR studies and assessed for maximal LV thickness of any segment and all 17 LV segments for presence of hypertrophy and LGE. CMR reports reviewed for: LVEDV, LVEF, and LV mass indexed to height 2.7 (LVMI) We evaluated the association of the above measurements to non-sustained VT and diastolic parameters by echo Primary Outcome: Non-sustained VT Secondary Outcome: Parameters of diastolic function assessed by echo Pre-Gadolinium LGE Distribution of LGE vs LVH NO LGE LGE Always with Hypertrophy LGE ± Hypertrophy Distribution of LGE N% LGE vs NO LGE CMR Measure LGE (n=17) No LGE (n=16) p-value LVEDV/m (±22.0)82.8 (±19.2)0.50 LVEF (%)65.6 (±14.3)71.4 (±6.3)0.15 LVMI (g/m 2.7 )67.2 (±33.5)42.3 (±15.1)0.01 Max Thickness (cm)2.5 (±1.1)1.5 (±0.3)< 0.01 # Segments with Hypertrophy 10 (7-11.5)7 (5-9)0.02 Echo Parameters of Diastolic Function Mitral E/e’10.4 (±3.4)8.2 (±2.8)0.06 Mitral E/A1.6 (±0.4)1.9 (±0.5)0.11 Non-Sustained VT vs no NSVT CMR Measure NSVT (n=7) No NSVT (n=26) Odds Ratio / p-value Presence of LGE (# of patients, %) 5 (71.4%)12 (46.2%) OR = 2.92 (0.48 –17.9) LGE < 5 segments2 (29%)24 (92%) OR = 0.06 ( ) LV Mass Index (g/m 2.7 )76.4 (±40.4)50.9 (±24.3)p = 0.03